MedlyPeds: a smartphone app to monitor kids with heart disease

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a prospective cohort feasibility study enrolling up to 30 pediatric patients with various heart conditions and up to 10 clinicians to test the MedlyPeds app over 3 months. Participants will provide quality of life data at baseline and at 3 months, plus feedback on the app through questionnaires and interviews. The goal is to identify which patient types benefit most and to gather user feedback for future refinement before a larger trial. Data from patients and clinicians will guide how MedlyPeds could be used in clinical monitoring. The study is conducted at The Hospital for Sick Children, in partnership with University Health Network in Toronto.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. Consent provided.
2. Aged 8-18 years of age.
3. Ability to comply with using Medly (ex. able to stand on the weight scale, able to answer symptom questions, etc.)
4. Followed at the Hospital for Sick Children Cardiology Clinic for any of the following reasons:

   1. Heart failure of any etiology
   2. Congenital heart disease
   3. Acquired heart disease (eg. Kawasaki disease, rheumatic heart disease, connective tissue disorders etc)
   4. Pulmonary hypertension
   5. Post-cardiac surgery including heart transplant and ventricular assist devices

Exclusion Criteria:

1. Unable to read or write in English.
2. Participating in another clinical trial that may confound the results.\* \*Participant may be re-screened for eligibility at a later date.

Where it's running

• The Hospital for Sick Children
  Toronto, Ontario, Canada Recruiting

Study contacts

• Study coordinator: Diana Balmer-Minnes
• Email: diana.balmer-minnes@sickkids.ca
• Phone: 416-813-7654

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Levosimendan to see if it helps the heart after PEA in CTEPH

  This small randomized trial tests whether giving levosimendan around surgery helps reduce pulmonary artery pressure and support right heart function after pulmonary endarterectomy for CTEPH.

  Recruiting Meshalkin Research Institute of Pathology of Circulation · Novosibirsk · NCT07914933

• Early treatment with inhaled treprostinil for exercise-induced pulmonary hypertension in ILD or CTD

  This study tests whether inhaled treprostinil added to standard care can improve exercise-related lung blood flow and function in adults with ILD or CTD who develop pulmonary hypertension during exercise.

  Recruiting at 2 sites Early Phase 1 Valley Health System · Paramus, New Jersey and 1 other locations · NCT07837830

• Brazilian Portuguese version of EmPHasis-10 for pulmonary hypertension

  This study tests a Brazilian Portuguese version of the EmPHasis-10 questionnaire to see if it reliably measures quality of life in adults with pulmonary hypertension in Porto Alegre, Brazil.

  Recruiting Hospital de Clinicas de Porto Alegre · Porto Alegre · NCT07822997

• Inhaled mosliciguat for pulmonary hypertension in interstitial lung disease (PH-ILD) patients

  This study tests inhaled mosliciguat versus placebo in people with PH-ILD to see if it helps with their condition.

  Recruiting at 3 sites Phase 3 Pulmovant, Inc. · Kissimmee, Florida and 2 other locations · NCT07816185

• Pulmonary Artery Denervation for Pulmonary Hypertension After M-TEER

  This study tests whether PADN can help people with pulmonary hypertension after M-TEER compared with standard medical therapy.

  Recruiting Early Phase 1 Xiamen Cardiovascular Hospital, Xiamen University · Xiamen, Fujian · NCT07662655

• Risk Factor Assessment for Acute Pulmonary Hypertension Crisis

  This study tests how to identify people with pulmonary hypertension who are at risk of a sudden, life-threatening crisis.

  Recruiting at 4 sites Peking Union Medical College Hospital · Guangzhou, Guangdong and 3 other locations · NCT07653958

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.